Skip to content

Author

Ali M. Almatri

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Rising burden of chronic kidney disease attributable to high fasting plasma glucose in the Middle East and North Africa, 1990-2023

Introduction: Chronic kidney disease (CKD) attributable to high fasting plasma glucose (HFPG) is rising globally, particularly in regions with rapidly increasing dysglycemia such as the Middle East and North Africa (MENA). We assessed long-term trends in HFPG-attributable CKD burden across 21 MENA countries from 1990 t...

Aya Abdulrahman Ajeel, Abdullah I. Alzimam, Sharifah Alraythi et al. · 0 citations
Review Open access Sep 2026

Efficacy of anlotinib plus immune checkpoint inhibitors in soft-tissue sarcoma: systematic review and meta-analysis.

BACKGROUND Advanced or metastatic soft-tissue sarcoma (STS) responds poorly to standard chemotherapy. Anlotinib has shown activity across multiple treatment lines, including first-line and maintenance therapies, though monotherapy benefit remains limited. This study aimed to quantify the efficacy of anlotinib plus PD-1...

Ahmed Farid Gadelmawla, Ahmed A. Abo Elnaga, A. Albukhari et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.